(Q43531444)

24 November 2017

title

Intranasal vaccines: forthcoming challenges (English)

1 reference

24 November 2017

Partidos CD

1

1 reference

24 November 2017

publication date

1 August 2000

1 reference

Pharmaceutical science & technology today

24 November 2017

published in

1 reference

24 November 2017

volume

3

1 reference

24 November 2017

issue

8

1 reference

24 November 2017

page(s)

273-281

1 reference

The mucosal immune system: from fundamental concepts to vaccine development

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

The role of nasopharyngeal lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

The Waldeyer Ring Equivalent in the Rat: a Model for Analysis of Oronasopharyngeal Immune Responses

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Immunology of the tonsils.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Antigen sampling across epithelial barriers and induction of mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

The effect of cholera toxin and cholera toxin B subunit on the nasal mucosal membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Nasal lymphoid tissue (NALT) as a mucosal immune inductive site

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Immunoglobulin A monoclonal antibodies protect against Sendai virus

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Detection of human cytokine-secreting cells in distinct anatomical compartments

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Host responses to respiratory virus infection and immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

The common mucosal immune system and current strategies for induction of immune responses in external secretions

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Advances in vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Heat-labile enterotoxin of Escherichia coli and its site-directed mutant LTK63 enhance the proliferative and cytotoxic T-cell responses to intranasally co-immunized synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

CpG-rich islands and the function of DNA methylation

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Antisense oligonucleotides: towards clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Activation of human B cells by phosphorothioate oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Fibronectin-binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

New use of BCG for recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Delivery of DNA vaccines by attenuated intracellular bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Mucosal and systemic immune responses to measles virus haemagglutinin in mice immunized with a recombinant vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Gene therapy: adenovirus vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Intranasal immunization with liposomes induces strong mucosal immune responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Immunological adjuvants: a role for liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

ISCOMS — a novel strategy for mucosal immunization?

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Iscoms with different quillaja saponin components differ in their immunomodulating activities

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Biodegradable microspheres as a vaccine delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Protection against vaginal SIV transmission with microencapsulated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Biodegradable microparticles as a delivery system for measles virus cytotoxic T cell epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Cationic microparticles: A potent delivery system for DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

Microencapsulated human parainfluenza virus induces a protective immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2800%2900281-9

7 January 2021

10.1016/S1461-5347(00)00281-9

Identifiers

DOI

1 reference

24 November 2017

1 reference